

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.13159037 |
| 2 | locomotory exploration behavior (GO:0035641) | 6.00202316 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.65057108 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.50363036 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 5.25260071 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.24222857 |
| 7 | vocalization behavior (GO:0071625) | 4.96367111 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.89929424 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.84239549 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.76175892 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.72960788 |
| 12 | regulation of synapse structural plasticity (GO:0051823) | 4.59672357 |
| 13 | glutamate secretion (GO:0014047) | 4.59614460 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 4.58994950 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.58563933 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.55210560 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48043103 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.48043103 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.48043103 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.48043103 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48043103 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48043103 |
| 23 | negative regulation of cell killing (GO:0031342) | 4.46965560 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.46965560 |
| 25 | sodium ion export (GO:0071436) | 4.38076405 |
| 26 | response to peptidoglycan (GO:0032494) | 4.37646878 |
| 27 | layer formation in cerebral cortex (GO:0021819) | 4.34634855 |
| 28 | exploration behavior (GO:0035640) | 4.21079453 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.18544049 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.18458277 |
| 31 | proline transport (GO:0015824) | 4.15938728 |
| 32 | cellular extravasation (GO:0045123) | 4.14544238 |
| 33 | cellular potassium ion homeostasis (GO:0030007) | 4.13610718 |
| 34 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.12370932 |
| 35 | neurotransmitter secretion (GO:0007269) | 4.10684115 |
| 36 | regulation of synaptic vesicle transport (GO:1902803) | 4.09249261 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 4.06209880 |
| 38 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.02969317 |
| 39 | activation of protein kinase A activity (GO:0034199) | 3.99540593 |
| 40 | detection of other organism (GO:0098543) | 3.94795604 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.93223273 |
| 42 | regulation of mast cell degranulation (GO:0043304) | 3.90874266 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.90350545 |
| 44 | glycine transport (GO:0015816) | 3.86858859 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.86586874 |
| 46 | positive regulation of mast cell activation (GO:0033005) | 3.86169041 |
| 47 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.78446737 |
| 48 | regulation of ARF protein signal transduction (GO:0032012) | 3.78214127 |
| 49 | negative regulation of interleukin-12 production (GO:0032695) | 3.77638393 |
| 50 | protein localization to synapse (GO:0035418) | 3.75789119 |
| 51 | regulation of leukocyte degranulation (GO:0043300) | 3.75507573 |
| 52 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.75484001 |
| 53 | neuromuscular process controlling balance (GO:0050885) | 3.73386093 |
| 54 | neuronal action potential propagation (GO:0019227) | 3.71453964 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.69361824 |
| 56 | neutrophil activation (GO:0042119) | 3.67613301 |
| 57 | dendritic spine morphogenesis (GO:0060997) | 3.67119501 |
| 58 | detection of bacterium (GO:0016045) | 3.66230547 |
| 59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.65434732 |
| 60 | long-term memory (GO:0007616) | 3.63073326 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.62623392 |
| 62 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.59006617 |
| 63 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.56215953 |
| 64 | synaptic transmission, glutamatergic (GO:0035249) | 3.50584687 |
| 65 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.50245866 |
| 66 | glutamate receptor signaling pathway (GO:0007215) | 3.46684160 |
| 67 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45836614 |
| 68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.45547574 |
| 69 | positive regulation of mast cell degranulation (GO:0043306) | 3.45547574 |
| 70 | regulation of mast cell activation (GO:0033003) | 3.43001449 |
| 71 | myeloid cell activation involved in immune response (GO:0002275) | 3.42484841 |
| 72 | L-amino acid import (GO:0043092) | 3.42132938 |
| 73 | granulocyte activation (GO:0036230) | 3.41497182 |
| 74 | regulation of regulated secretory pathway (GO:1903305) | 3.40148619 |
| 75 | microglial cell activation (GO:0001774) | 3.40075805 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 3.39071339 |
| 77 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.38135965 |
| 78 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.37789417 |
| 79 | response to muramyl dipeptide (GO:0032495) | 3.35546444 |
| 80 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.34194287 |
| 81 | prepulse inhibition (GO:0060134) | 3.33957199 |
| 82 | macrophage activation (GO:0042116) | 3.33947086 |
| 83 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33718546 |
| 84 | detection of external biotic stimulus (GO:0098581) | 3.33707450 |
| 85 | synaptic vesicle endocytosis (GO:0048488) | 3.32676671 |
| 86 | detection of molecule of bacterial origin (GO:0032490) | 3.32345209 |
| 87 | positive regulation of membrane potential (GO:0045838) | 3.31918108 |
| 88 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.31552748 |
| 89 | immunoglobulin mediated immune response (GO:0016064) | 3.31048231 |
| 90 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.28173642 |
| 91 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.24860477 |
| 92 | dendrite morphogenesis (GO:0048813) | 3.22966449 |
| 93 | neuron-neuron synaptic transmission (GO:0007270) | 3.22888047 |
| 94 | neurotransmitter transport (GO:0006836) | 3.22403067 |
| 95 | response to host immune response (GO:0052572) | 3.21564228 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.21564228 |
| 97 | clathrin coat assembly (GO:0048268) | 3.21089159 |
| 98 | response to auditory stimulus (GO:0010996) | 3.20961929 |
| 99 | cell communication by electrical coupling (GO:0010644) | 3.18419929 |
| 100 | potassium ion import (GO:0010107) | 3.18048020 |
| 101 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.17347633 |
| 102 | auditory behavior (GO:0031223) | 3.17198364 |
| 103 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.14139395 |
| 104 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.14085532 |
| 105 | regulation of postsynaptic membrane potential (GO:0060078) | 3.13806277 |
| 106 | regulation of synaptic plasticity (GO:0048167) | 3.13041263 |
| 107 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.10312694 |
| 108 | positive regulation of synapse maturation (GO:0090129) | 3.09471006 |
| 109 | alanine transport (GO:0032328) | 3.08548221 |
| 110 | vesicle transport along microtubule (GO:0047496) | 3.07418013 |
| 111 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.06597674 |
| 112 | neuron cell-cell adhesion (GO:0007158) | 3.05870907 |
| 113 | mannose metabolic process (GO:0006013) | 3.05712892 |
| 114 | membrane depolarization during action potential (GO:0086010) | 3.05180443 |
| 115 | leukocyte degranulation (GO:0043299) | 3.02118260 |
| 116 | positive regulation of regulated secretory pathway (GO:1903307) | 3.01963510 |
| 117 | regulation of neurotransmitter levels (GO:0001505) | 3.01960756 |
| 118 | regulation of neurotransmitter secretion (GO:0046928) | 3.01187031 |
| 119 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.99787328 |
| 120 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.99403302 |
| 121 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.99268172 |
| 122 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.99114418 |
| 123 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97909313 |
| 124 | detection of biotic stimulus (GO:0009595) | 2.96483974 |
| 125 | regulation of ARF GTPase activity (GO:0032312) | 2.95094856 |
| 126 | positive regulation of fibroblast migration (GO:0010763) | 2.93466732 |
| 127 | positive regulation of leukocyte degranulation (GO:0043302) | 2.93144914 |
| 128 | response to host (GO:0075136) | 2.91453612 |
| 129 | response to host defenses (GO:0052200) | 2.91453612 |
| 130 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91453612 |
| 131 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.90910131 |
| 132 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.89225891 |
| 133 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.87822481 |
| 134 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.87709178 |
| 135 | negative regulation of T cell mediated immunity (GO:0002710) | 2.86438776 |
| 136 | cellular sodium ion homeostasis (GO:0006883) | 2.86328977 |
| 137 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.86043401 |
| 138 | positive regulation of neurotransmitter transport (GO:0051590) | 2.85613381 |
| 139 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.85563378 |
| 140 | respiratory burst (GO:0045730) | 2.85193514 |
| 141 | membrane depolarization (GO:0051899) | 2.83359120 |
| 142 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.83187173 |
| 143 | neuromuscular process controlling posture (GO:0050884) | 2.82795928 |
| 144 | transmission of nerve impulse (GO:0019226) | 2.82750444 |
| 145 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81718541 |
| 146 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.81504067 |
| 147 | regulation of platelet aggregation (GO:0090330) | 2.80115090 |
| 148 | long-term synaptic potentiation (GO:0060291) | 2.79499244 |
| 149 | actin filament capping (GO:0051693) | 2.79251319 |
| 150 | regulation of neurotransmitter transport (GO:0051588) | 2.79038368 |
| 151 | establishment of nucleus localization (GO:0040023) | 2.77851804 |
| 152 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76211299 |
| 153 | B cell receptor signaling pathway (GO:0050853) | 2.75203586 |
| 154 | dopamine receptor signaling pathway (GO:0007212) | 2.74184678 |
| 155 | nerve growth factor signaling pathway (GO:0038180) | 2.73446068 |
| 156 | neuromuscular process (GO:0050905) | 2.73180669 |
| 157 | positive thymic T cell selection (GO:0045059) | 2.72198648 |
| 158 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70950779 |
| 159 | membrane hyperpolarization (GO:0060081) | 2.69948389 |
| 160 | regulation of dendritic spine development (GO:0060998) | 2.69123753 |
| 161 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.68581657 |
| 162 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.67942599 |
| 163 | amino acid import (GO:0043090) | 2.67669174 |
| 164 | positive regulation of synaptic transmission (GO:0050806) | 2.67420794 |
| 165 | leukocyte aggregation (GO:0070486) | 2.67307642 |
| 166 | germinal center formation (GO:0002467) | 2.67003965 |
| 167 | neuronal ion channel clustering (GO:0045161) | 2.65856830 |
| 168 | potassium ion homeostasis (GO:0055075) | 2.63480731 |
| 169 | intraspecies interaction between organisms (GO:0051703) | 2.63444542 |
| 170 | social behavior (GO:0035176) | 2.63444542 |
| 171 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.62620321 |
| 172 | thrombin receptor signaling pathway (GO:0070493) | 2.62288647 |
| 173 | cAMP biosynthetic process (GO:0006171) | 2.61479707 |
| 174 | adult walking behavior (GO:0007628) | 2.61099535 |
| 175 | positive regulation of antigen processing and presentation (GO:0002579) | 2.60938926 |
| 176 | regulation of vesicle fusion (GO:0031338) | 2.58963854 |
| 177 | negative regulation of interleukin-17 production (GO:0032700) | 2.58874505 |
| 178 | neuron recognition (GO:0008038) | 2.58548895 |
| 179 | actin filament polymerization (GO:0030041) | 2.58054252 |
| 180 | positive regulation of Rap GTPase activity (GO:0032854) | 2.57600321 |
| 181 | neutrophil chemotaxis (GO:0030593) | 2.56870718 |
| 182 | regulation of B cell differentiation (GO:0045577) | 2.56749860 |
| 183 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.55893591 |
| 184 | regulation of platelet activation (GO:0010543) | 2.55185073 |
| 185 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.54322441 |
| 186 | positive regulation of type 2 immune response (GO:0002830) | 2.52121369 |
| 187 | myeloid leukocyte activation (GO:0002274) | 2.51846888 |
| 188 | neutrophil migration (GO:1990266) | 2.49530836 |
| 189 | negative regulation of innate immune response (GO:0045824) | 2.48879386 |
| 190 | neutrophil mediated immunity (GO:0002446) | 2.47086649 |
| 191 | regulation of tolerance induction (GO:0002643) | 2.43702904 |
| 192 | megakaryocyte development (GO:0035855) | 2.42855963 |
| 193 | regulation of antigen processing and presentation (GO:0002577) | 2.41899535 |
| 194 | activated T cell proliferation (GO:0050798) | 2.41449904 |
| 195 | endothelium development (GO:0003158) | 2.40164924 |
| 196 | negative thymic T cell selection (GO:0045060) | 2.39732528 |
| 197 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.39432753 |
| 198 | B cell mediated immunity (GO:0019724) | 2.38833500 |
| 199 | response to interleukin-15 (GO:0070672) | 2.38049332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.54884898 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.35499337 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.05158510 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.15004288 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.10192277 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.04168064 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.92727836 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88271924 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.77177850 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.74184345 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66556181 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.64838905 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.58071356 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.56211941 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.54754935 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49994706 |
| 17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49143865 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.48536621 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.46177794 |
| 20 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39263967 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39193608 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39193608 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.34386401 |
| 24 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33871207 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.33435837 |
| 26 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30556343 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.24412309 |
| 28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.22480189 |
| 29 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.19365531 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.18734269 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.14695858 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.14519206 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13585705 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.08823535 |
| 35 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.08165460 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06748923 |
| 37 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06511053 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.98240138 |
| 39 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96243386 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.95266681 |
| 41 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92930179 |
| 42 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.92107844 |
| 43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.92079585 |
| 44 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.89985668 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.85500117 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85332952 |
| 47 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84810845 |
| 48 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.81222866 |
| 49 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.77197127 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.74519789 |
| 51 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.73967753 |
| 52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73795141 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71516774 |
| 54 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.71376108 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.69357542 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.68794240 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68729089 |
| 58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.67665812 |
| 59 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66725950 |
| 60 | * MAF_26560356_Chip-Seq_TH1_Human | 1.65582397 |
| 61 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.62459373 |
| 62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.60748617 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.60435948 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59357893 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.58985769 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.57765815 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57594929 |
| 68 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57197779 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.55955840 |
| 70 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.54920778 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.54516925 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52894790 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52637825 |
| 74 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51981894 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51933227 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.50591845 |
| 77 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48511121 |
| 78 | MYB_26560356_Chip-Seq_TH2_Human | 1.48040247 |
| 79 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44638743 |
| 80 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40577495 |
| 81 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.39635399 |
| 82 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.37388317 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36484259 |
| 84 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.35811329 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35263678 |
| 86 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34666783 |
| 87 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.31584496 |
| 88 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31468019 |
| 89 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.28616186 |
| 90 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.28541607 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 1.28443572 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27534685 |
| 93 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25707871 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24370274 |
| 95 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21971480 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21574052 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19132486 |
| 98 | AR_19668381_ChIP-Seq_PC3_Human | 1.18858214 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.18125188 |
| 100 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17726313 |
| 101 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17488197 |
| 102 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17347567 |
| 103 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17009624 |
| 104 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16852738 |
| 105 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16140801 |
| 106 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15823936 |
| 107 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15630375 |
| 108 | * MAF_26560356_Chip-Seq_TH2_Human | 1.15372734 |
| 109 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14551226 |
| 110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14308685 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11562017 |
| 112 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10557483 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10509432 |
| 114 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.10050107 |
| 115 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09603141 |
| 116 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.08190911 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08129726 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07906129 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05807928 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05265742 |
| 121 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05038794 |
| 122 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03198238 |
| 123 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02631559 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02562918 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02105359 |
| 126 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01896856 |
| 127 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01670055 |
| 128 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99720997 |
| 129 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.99694399 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99062790 |
| 131 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.98834744 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98018884 |
| 133 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97996013 |
| 134 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.97605643 |
| 135 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.97574968 |
| 136 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97092773 |
| 137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95994913 |
| 138 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95410429 |
| 139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94176747 |
| 140 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94094969 |
| 141 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.93609317 |
| 142 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93484265 |
| 143 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93360709 |
| 144 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92473118 |
| 145 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.92368956 |
| 146 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92261930 |
| 147 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.92215922 |
| 148 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92160555 |
| 149 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92016857 |
| 150 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91941470 |
| 151 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91781577 |
| 152 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91540873 |
| 153 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91398652 |
| 154 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91143202 |
| 155 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90981366 |
| 156 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90691591 |
| 157 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90578539 |
| 158 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90241176 |
| 159 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89978884 |
| 160 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89538192 |
| 161 | P68_20966046_ChIP-Seq_HELA_Human | 0.89258144 |
| 162 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89102671 |
| 163 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88633699 |
| 164 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.87604945 |
| 165 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87603052 |
| 166 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87091079 |
| 167 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86563515 |
| 168 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86314857 |
| 169 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85673358 |
| 170 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85525484 |
| 171 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85307792 |
| 172 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84760812 |
| 173 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.84156923 |
| 174 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83669256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.20266334 |
| 2 | MP0003724_increased_susceptibility_to | 4.37406301 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.10739504 |
| 4 | MP0003880_abnormal_central_pattern | 3.43736996 |
| 5 | MP0003436_decreased_susceptibility_to | 3.42886783 |
| 6 | MP0004270_analgesia | 3.38560359 |
| 7 | MP0009046_muscle_twitch | 3.20127129 |
| 8 | MP0009745_abnormal_behavioral_response | 3.19582475 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.13066014 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.04695253 |
| 11 | MP0002822_catalepsy | 3.04105502 |
| 12 | MP0002064_seizures | 3.00978651 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.92731950 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.83493390 |
| 15 | MP0002419_abnormal_innate_immunity | 2.75077389 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.70794198 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.66448626 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.47561502 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.47548130 |
| 20 | MP0005025_abnormal_response_to | 2.39096079 |
| 21 | MP0001486_abnormal_startle_reflex | 2.34574126 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 2.34365147 |
| 23 | MP0002736_abnormal_nociception_after | 2.26713694 |
| 24 | MP0003828_pulmonary_edema | 2.26197548 |
| 25 | MP0004858_abnormal_nervous_system | 2.23339772 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.22806275 |
| 27 | MP0002735_abnormal_chemical_nociception | 2.22530740 |
| 28 | MP0009278_abnormal_bone_marrow | 2.22458496 |
| 29 | MP0002272_abnormal_nervous_system | 2.19129509 |
| 30 | MP0008569_lethality_at_weaning | 2.17154993 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 2.15708708 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 2.11715986 |
| 33 | MP0006082_CNS_inflammation | 2.11371900 |
| 34 | MP0002909_abnormal_adrenal_gland | 2.10472595 |
| 35 | MP0001501_abnormal_sleep_pattern | 2.09035493 |
| 36 | MP0005671_abnormal_response_to | 2.07225733 |
| 37 | MP0002733_abnormal_thermal_nociception | 2.04987402 |
| 38 | MP0005387_immune_system_phenotype | 2.04555088 |
| 39 | MP0001790_abnormal_immune_system | 2.04555088 |
| 40 | MP0002723_abnormal_immune_serum | 2.02559220 |
| 41 | MP0001800_abnormal_humoral_immune | 1.98633048 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.97430441 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.95449280 |
| 44 | MP0001819_abnormal_immune_cell | 1.94407327 |
| 45 | MP0004811_abnormal_neuron_physiology | 1.94194692 |
| 46 | MP0001970_abnormal_pain_threshold | 1.93910933 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.91473933 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.91473933 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.90588768 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.89389253 |
| 51 | MP0004147_increased_porphyrin_level | 1.86611567 |
| 52 | MP0009785_altered_susceptibility_to | 1.86549853 |
| 53 | MP0003329_amyloid_beta_deposits | 1.86052016 |
| 54 | MP0001440_abnormal_grooming_behavior | 1.84969929 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.81844900 |
| 56 | MP0000685_abnormal_immune_system | 1.81645274 |
| 57 | MP0002067_abnormal_sensory_capabilities | 1.75342424 |
| 58 | MP0003075_altered_response_to | 1.66745438 |
| 59 | MP0008260_abnormal_autophagy | 1.65620187 |
| 60 | MP0003633_abnormal_nervous_system | 1.65194340 |
| 61 | MP0008004_abnormal_stomach_pH | 1.64954111 |
| 62 | MP0009840_abnormal_foam_cell | 1.62300856 |
| 63 | MP0003303_peritoneal_inflammation | 1.61509544 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.60250857 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.60023524 |
| 66 | MP0004885_abnormal_endolymph | 1.59350459 |
| 67 | MP0004947_skin_inflammation | 1.58384396 |
| 68 | MP0003690_abnormal_glial_cell | 1.58160822 |
| 69 | MP0002405_respiratory_system_inflammati | 1.55808097 |
| 70 | MP0002557_abnormal_social/conspecific_i | 1.54736930 |
| 71 | MP0004924_abnormal_behavior | 1.52690198 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.52690198 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.50151004 |
| 74 | MP0008961_abnormal_basal_metabolism | 1.49663103 |
| 75 | MP0002398_abnormal_bone_marrow | 1.47304821 |
| 76 | MP0003879_abnormal_hair_cell | 1.46002535 |
| 77 | MP0000716_abnormal_immune_system | 1.44601124 |
| 78 | MP0001851_eye_inflammation | 1.43520345 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.42839423 |
| 80 | MP0003866_abnormal_defecation | 1.39316972 |
| 81 | MP0002184_abnormal_innervation | 1.37298868 |
| 82 | MP0000955_abnormal_spinal_cord | 1.34883436 |
| 83 | MP0000343_altered_response_to | 1.33514694 |
| 84 | MP0009764_decreased_sensitivity_to | 1.31547187 |
| 85 | MP0000604_amyloidosis | 1.29204171 |
| 86 | MP0003631_nervous_system_phenotype | 1.28599962 |
| 87 | MP0000778_abnormal_nervous_system | 1.28313959 |
| 88 | MP0000015_abnormal_ear_pigmentation | 1.27870500 |
| 89 | MP0004510_myositis | 1.26902814 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.26819719 |
| 91 | MP0008872_abnormal_physiological_respon | 1.25088238 |
| 92 | MP0005646_abnormal_pituitary_gland | 1.23682965 |
| 93 | MP0003763_abnormal_thymus_physiology | 1.22545670 |
| 94 | MP0002429_abnormal_blood_cell | 1.20611855 |
| 95 | MP0008469_abnormal_protein_level | 1.20283923 |
| 96 | MP0000689_abnormal_spleen_morphology | 1.20109297 |
| 97 | MP0003787_abnormal_imprinting | 1.19355796 |
| 98 | MP0002882_abnormal_neuron_morphology | 1.18324903 |
| 99 | MP0008874_decreased_physiological_sensi | 1.15675042 |
| 100 | MP0003300_gastrointestinal_ulcer | 1.15443326 |
| 101 | MP0002132_abnormal_respiratory_system | 1.13820178 |
| 102 | MP0004130_abnormal_muscle_cell | 1.12103780 |
| 103 | MP0002722_abnormal_immune_system | 1.11444385 |
| 104 | MP0004883_abnormal_blood_vessel | 1.08593308 |
| 105 | MP0000858_altered_metastatic_potential | 1.07459021 |
| 106 | MP0004808_abnormal_hematopoietic_stem | 1.01360275 |
| 107 | MP0002396_abnormal_hematopoietic_system | 1.01230420 |
| 108 | MP0005451_abnormal_body_composition | 1.01073353 |
| 109 | MP0005083_abnormal_biliary_tract | 1.00431051 |
| 110 | MP0001177_atelectasis | 0.95358301 |
| 111 | MP0000249_abnormal_blood_vessel | 0.95098903 |
| 112 | MP0002152_abnormal_brain_morphology | 0.93619892 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.91884645 |
| 114 | MP0003634_abnormal_glial_cell | 0.91689664 |
| 115 | MP0009115_abnormal_fat_cell | 0.88761524 |
| 116 | MP0005166_decreased_susceptibility_to | 0.88651299 |
| 117 | MP0005164_abnormal_response_to | 0.87565771 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.87527557 |
| 119 | MP0000920_abnormal_myelination | 0.86295758 |
| 120 | MP0003632_abnormal_nervous_system | 0.85998349 |
| 121 | MP0001853_heart_inflammation | 0.85768768 |
| 122 | MP0005645_abnormal_hypothalamus_physiol | 0.85654651 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.85583607 |
| 124 | MP0001502_abnormal_circadian_rhythm | 0.85197041 |
| 125 | MP0005535_abnormal_body_temperature | 0.85026178 |
| 126 | MP0002229_neurodegeneration | 0.84772258 |
| 127 | MP0005365_abnormal_bile_salt | 0.83580682 |
| 128 | MP0003283_abnormal_digestive_organ | 0.81271968 |
| 129 | MP0010234_abnormal_vibrissa_follicle | 0.80652754 |
| 130 | MP0002090_abnormal_vision | 0.80398854 |
| 131 | MP0001663_abnormal_digestive_system | 0.80353963 |
| 132 | MP0002069_abnormal_eating/drinking_beha | 0.80311368 |
| 133 | MP0000751_myopathy | 0.79563703 |
| 134 | MP0000703_abnormal_thymus_morphology | 0.78962509 |
| 135 | MP0003045_fibrosis | 0.77831825 |
| 136 | MP0006054_spinal_hemorrhage | 0.77583333 |
| 137 | MP0000013_abnormal_adipose_tissue | 0.75596337 |
| 138 | MP0004381_abnormal_hair_follicle | 0.75375853 |
| 139 | MP0001986_abnormal_taste_sensitivity | 0.73288167 |
| 140 | MP0001984_abnormal_olfaction | 0.72990410 |
| 141 | MP0004142_abnormal_muscle_tone | 0.71135952 |
| 142 | MP0002118_abnormal_lipid_homeostasis | 0.70193364 |
| 143 | * MP0004085_abnormal_heartbeat | 0.69306420 |
| 144 | MP0005390_skeleton_phenotype | 0.68867792 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.68825227 |
| 146 | MP0005647_abnormal_sex_gland | 0.67441700 |
| 147 | MP0005165_increased_susceptibility_to | 0.67120807 |
| 148 | MP0002166_altered_tumor_susceptibility | 0.66908275 |
| 149 | MP0003091_abnormal_cell_migration | 0.65322045 |
| 150 | MP0002332_abnormal_exercise_endurance | 0.65224215 |
| 151 | MP0009763_increased_sensitivity_to | 0.64914604 |
| 152 | MP0002933_joint_inflammation | 0.64673945 |
| 153 | MP0002138_abnormal_hepatobiliary_system | 0.64044333 |
| 154 | MP0002971_abnormal_brown_adipose | 0.62365366 |
| 155 | MP0005058_abnormal_lysosome_morphology | 0.62017560 |
| 156 | MP0002089_abnormal_postnatal_growth/wei | 0.61048492 |
| 157 | MP0003448_altered_tumor_morphology | 0.60967740 |
| 158 | MP0004484_altered_response_of | 0.59924304 |
| 159 | MP0006276_abnormal_autonomic_nervous | 0.55509706 |
| 160 | MP0004742_abnormal_vestibular_system | 0.54638711 |
| 161 | MP0001664_abnormal_digestion | 0.54506083 |
| 162 | MP0005409_darkened_coat_color | 0.53282622 |
| 163 | MP0010386_abnormal_urinary_bladder | 0.51870934 |
| 164 | MP0005464_abnormal_platelet_physiology | 0.51641695 |
| 165 | MP0010769_abnormal_survival | 0.51432039 |
| 166 | MP0001299_abnormal_eye_distance/ | 0.49683185 |
| 167 | MP0001958_emphysema | 0.48038984 |
| 168 | MP0004215_abnormal_myocardial_fiber | 0.47496134 |
| 169 | MP0005310_abnormal_salivary_gland | 0.47143175 |
| 170 | MP0010768_mortality/aging | 0.46782154 |
| 171 | MP0008770_decreased_survivor_rate | 0.46676574 |
| 172 | MP0002082_postnatal_lethality | 0.46304336 |
| 173 | MP0010770_preweaning_lethality | 0.46304336 |
| 174 | MP0001905_abnormal_dopamine_level | 0.45001754 |
| 175 | MP0005174_abnormal_tail_pigmentation | 0.44709934 |
| 176 | MP0005623_abnormal_meninges_morphology | 0.43796111 |
| 177 | MP0003956_abnormal_body_size | 0.43693684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.19553980 |
| 2 | Focal motor seizures (HP:0011153) | 5.64287962 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.24528992 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.05845252 |
| 5 | Focal seizures (HP:0007359) | 4.92686920 |
| 6 | Prolonged bleeding time (HP:0003010) | 4.92099347 |
| 7 | Visual hallucinations (HP:0002367) | 4.76634825 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.74219223 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.66042340 |
| 10 | Action tremor (HP:0002345) | 4.31268826 |
| 11 | Myositis (HP:0100614) | 4.09908988 |
| 12 | Spontaneous hematomas (HP:0007420) | 4.07928951 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.95327702 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.92997443 |
| 15 | Papilledema (HP:0001085) | 3.92016408 |
| 16 | Stomatitis (HP:0010280) | 3.86081270 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.79797421 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.77690717 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.77690717 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.77690717 |
| 21 | Petechiae (HP:0000967) | 3.77001359 |
| 22 | Epistaxis (HP:0000421) | 3.71808414 |
| 23 | Purpura (HP:0000979) | 3.67247868 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.65117039 |
| 25 | Orchitis (HP:0100796) | 3.63985487 |
| 26 | Febrile seizures (HP:0002373) | 3.49408678 |
| 27 | Insomnia (HP:0100785) | 3.48019545 |
| 28 | Postural instability (HP:0002172) | 3.45992544 |
| 29 | Ankle clonus (HP:0011448) | 3.43781994 |
| 30 | Epileptic encephalopathy (HP:0200134) | 3.43761897 |
| 31 | Mutism (HP:0002300) | 3.43189867 |
| 32 | Depression (HP:0000716) | 3.42176092 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 3.40560549 |
| 34 | Optic neuritis (HP:0100653) | 3.40560549 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.32789486 |
| 36 | Hemiplegia (HP:0002301) | 3.27976436 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 3.25183581 |
| 38 | Obstructive lung disease (HP:0006536) | 3.25183581 |
| 39 | Gingival bleeding (HP:0000225) | 3.24813281 |
| 40 | Generalized tonic-clonic seizures (HP:0002069) | 3.22192648 |
| 41 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.20887906 |
| 42 | Dysostosis multiplex (HP:0000943) | 3.17244564 |
| 43 | Poor eye contact (HP:0000817) | 3.17159798 |
| 44 | Recurrent fungal infections (HP:0002841) | 3.14347454 |
| 45 | Impaired social interactions (HP:0000735) | 3.11375005 |
| 46 | Abnormal social behavior (HP:0012433) | 3.11375005 |
| 47 | Amyloidosis (HP:0011034) | 3.07878123 |
| 48 | Atonic seizures (HP:0010819) | 3.04912551 |
| 49 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.02168468 |
| 50 | Abnormality of binocular vision (HP:0011514) | 3.01745017 |
| 51 | Diplopia (HP:0000651) | 3.01745017 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.98790638 |
| 53 | Recurrent skin infections (HP:0001581) | 2.98643161 |
| 54 | Menorrhagia (HP:0000132) | 2.98028232 |
| 55 | Absence seizures (HP:0002121) | 2.95067558 |
| 56 | Abnormal platelet volume (HP:0011876) | 2.93722767 |
| 57 | Gaze-evoked nystagmus (HP:0000640) | 2.88107626 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.86731014 |
| 59 | Truncal ataxia (HP:0002078) | 2.85317726 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.85007089 |
| 61 | Dysdiadochokinesis (HP:0002075) | 2.84026966 |
| 62 | Annular pancreas (HP:0001734) | 2.83915322 |
| 63 | Gingivitis (HP:0000230) | 2.82101113 |
| 64 | Impaired smooth pursuit (HP:0007772) | 2.79470569 |
| 65 | Dysmetric saccades (HP:0000641) | 2.77611326 |
| 66 | Broad-based gait (HP:0002136) | 2.74454842 |
| 67 | Abnormal eating behavior (HP:0100738) | 2.73552234 |
| 68 | Urinary urgency (HP:0000012) | 2.72204322 |
| 69 | Intention tremor (HP:0002080) | 2.69140367 |
| 70 | Anxiety (HP:0000739) | 2.68994155 |
| 71 | Dialeptic seizures (HP:0011146) | 2.68193135 |
| 72 | Impaired platelet aggregation (HP:0003540) | 2.66342198 |
| 73 | Abnormal platelet function (HP:0011869) | 2.66342198 |
| 74 | Genetic anticipation (HP:0003743) | 2.65568298 |
| 75 | Pointed chin (HP:0000307) | 2.65018103 |
| 76 | Dysmetria (HP:0001310) | 2.62895358 |
| 77 | Abnormality of the lower motor neuron (HP:0002366) | 2.62020273 |
| 78 | Loss of speech (HP:0002371) | 2.61738315 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.59963383 |
| 80 | Meningitis (HP:0001287) | 2.57416915 |
| 81 | Hematochezia (HP:0002573) | 2.55451784 |
| 82 | Increased mean platelet volume (HP:0011877) | 2.53999091 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.53029952 |
| 84 | Episodic fever (HP:0001954) | 2.52944046 |
| 85 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.50212647 |
| 86 | Gastrointestinal infarctions (HP:0005244) | 2.50060739 |
| 87 | Encephalitis (HP:0002383) | 2.48188053 |
| 88 | Recurrent cutaneous fungal infections (HP:0011370) | 2.47389018 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.47389018 |
| 90 | Torticollis (HP:0000473) | 2.46903651 |
| 91 | Poikilocytosis (HP:0004447) | 2.46881076 |
| 92 | Increased IgE level (HP:0003212) | 2.46687864 |
| 93 | Stereotypic behavior (HP:0000733) | 2.46277434 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 2.44780173 |
| 95 | Lower limb amyotrophy (HP:0007210) | 2.44417886 |
| 96 | Increased serum ferritin (HP:0003281) | 2.43904707 |
| 97 | Hyperacusis (HP:0010780) | 2.42826510 |
| 98 | Hemoptysis (HP:0002105) | 2.41448234 |
| 99 | Hemiparesis (HP:0001269) | 2.40624020 |
| 100 | Bradykinesia (HP:0002067) | 2.40408507 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 2.39851566 |
| 102 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.39627728 |
| 103 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.39627728 |
| 104 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.39627728 |
| 105 | Vasculitis (HP:0002633) | 2.38955888 |
| 106 | Cellulitis (HP:0100658) | 2.37993368 |
| 107 | Chest pain (HP:0100749) | 2.37828835 |
| 108 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37624144 |
| 109 | Urticaria (HP:0001025) | 2.35956880 |
| 110 | Ventricular fibrillation (HP:0001663) | 2.35180548 |
| 111 | Disinhibition (HP:0000734) | 2.34818574 |
| 112 | Pulmonary embolism (HP:0002204) | 2.34044148 |
| 113 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33492608 |
| 114 | Mucopolysacchariduria (HP:0008155) | 2.33492608 |
| 115 | Arterial thrombosis (HP:0004420) | 2.32479169 |
| 116 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.31644986 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 2.31108263 |
| 118 | Progressive inability to walk (HP:0002505) | 2.30826071 |
| 119 | Status epilepticus (HP:0002133) | 2.29935048 |
| 120 | Pustule (HP:0200039) | 2.27790722 |
| 121 | Spastic gait (HP:0002064) | 2.25677969 |
| 122 | Autoimmune thrombocytopenia (HP:0001973) | 2.25295779 |
| 123 | Keratoconjunctivitis (HP:0001096) | 2.24651572 |
| 124 | Megalencephaly (HP:0001355) | 2.23867442 |
| 125 | Apathy (HP:0000741) | 2.23562146 |
| 126 | Inflammation of the large intestine (HP:0002037) | 2.23097659 |
| 127 | Cerebral inclusion bodies (HP:0100314) | 2.22597872 |
| 128 | Resting tremor (HP:0002322) | 2.22186835 |
| 129 | Scanning speech (HP:0002168) | 2.21617580 |
| 130 | Gastrointestinal inflammation (HP:0004386) | 2.20237129 |
| 131 | Inappropriate behavior (HP:0000719) | 2.18555237 |
| 132 | Leukocytosis (HP:0001974) | 2.17432682 |
| 133 | Pulmonary infiltrates (HP:0002113) | 2.16886359 |
| 134 | Bundle branch block (HP:0011710) | 2.16511717 |
| 135 | Neurofibrillary tangles (HP:0002185) | 2.15775680 |
| 136 | Myocardial infarction (HP:0001658) | 2.14584095 |
| 137 | Termporal pattern (HP:0011008) | 2.13648632 |
| 138 | Insidious onset (HP:0003587) | 2.13648632 |
| 139 | Increased cerebral lipofuscin (HP:0011813) | 2.13514376 |
| 140 | Focal dystonia (HP:0004373) | 2.12928994 |
| 141 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.12395159 |
| 142 | Lower limb muscle weakness (HP:0007340) | 2.11463996 |
| 143 | Macroorchidism (HP:0000053) | 2.10159340 |
| 144 | Elfin facies (HP:0004428) | 2.09712218 |
| 145 | Vertigo (HP:0002321) | 2.09331302 |
| 146 | Obstructive sleep apnea (HP:0002870) | 2.09229762 |
| 147 | Impaired vibratory sensation (HP:0002495) | 2.08299823 |
| 148 | Rapidly progressive (HP:0003678) | 2.06822916 |
| 149 | Hepatosplenomegaly (HP:0001433) | 2.03695467 |
| 150 | Reticulocytosis (HP:0001923) | 2.03620194 |
| 151 | Clumsiness (HP:0002312) | 2.03043220 |
| 152 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02819502 |
| 153 | Colitis (HP:0002583) | 2.01844847 |
| 154 | Abnormality of saccadic eye movements (HP:0000570) | 2.01411372 |
| 155 | Recurrent viral infections (HP:0004429) | 2.00613686 |
| 156 | Excessive salivation (HP:0003781) | 1.99252766 |
| 157 | Drooling (HP:0002307) | 1.99252766 |
| 158 | Slow saccadic eye movements (HP:0000514) | 1.99199643 |
| 159 | Abnormality of the periventricular white matter (HP:0002518) | 1.99044356 |
| 160 | Diminished motivation (HP:0000745) | 1.98673864 |
| 161 | Osteomyelitis (HP:0002754) | 1.98007057 |
| 162 | Hypochromic anemia (HP:0001931) | 1.94540959 |
| 163 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93051454 |
| 164 | Craniofacial dystonia (HP:0012179) | 1.91158436 |
| 165 | Spinal canal stenosis (HP:0003416) | 1.87616937 |
| 166 | Conjunctival telangiectasia (HP:0000524) | 1.85921969 |
| 167 | Rigidity (HP:0002063) | 1.85206365 |
| 168 | Ankyloglossia (HP:0010296) | 1.83370112 |
| 169 | Clonus (HP:0002169) | 1.83334843 |
| 170 | Amblyopia (HP:0000646) | 1.82816737 |
| 171 | Hemorrhage of the eye (HP:0011885) | 1.82359272 |
| 172 | Psychosis (HP:0000709) | 1.81869154 |
| 173 | Fatigue (HP:0012378) | 1.81101996 |
| 174 | Granulocytopenia (HP:0001913) | 1.80649360 |
| 175 | Lower limb asymmetry (HP:0100559) | 1.79329892 |
| 176 | Aqueductal stenosis (HP:0002410) | 1.77892610 |
| 177 | Abnormality of the corticospinal tract (HP:0002492) | 1.76662593 |
| 178 | Incomplete penetrance (HP:0003829) | 1.75717330 |
| 179 | Upper limb amyotrophy (HP:0009129) | 1.70421721 |
| 180 | Distal upper limb amyotrophy (HP:0007149) | 1.70421721 |
| 181 | Agitation (HP:0000713) | 1.69249969 |
| 182 | Polycythemia (HP:0001901) | 1.67617304 |
| 183 | Absent speech (HP:0001344) | 1.65875060 |
| 184 | Gait ataxia (HP:0002066) | 1.64402759 |
| 185 | Polygenic inheritance (HP:0010982) | 1.64273467 |
| 186 | Amyotrophic lateral sclerosis (HP:0007354) | 1.64012839 |
| 187 | Cerebral aneurysm (HP:0004944) | 1.63365312 |
| 188 | Polyphagia (HP:0002591) | 1.60862886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.89685754 |
| 2 | NTRK3 | 3.71483865 |
| 3 | EPHA4 | 3.56431910 |
| 4 | DAPK2 | 3.17481281 |
| 5 | MARK1 | 2.88918740 |
| 6 | BLK | 2.79694289 |
| 7 | MAP4K1 | 2.60564900 |
| 8 | CAMKK1 | 2.51416087 |
| 9 | MAP3K4 | 2.47465323 |
| 10 | MAP2K3 | 2.47284192 |
| 11 | MINK1 | 2.41547699 |
| 12 | KSR2 | 2.33695101 |
| 13 | RIPK4 | 2.27783212 |
| 14 | PAK6 | 2.17592541 |
| 15 | ZAP70 | 2.14996072 |
| 16 | PRKD3 | 2.14462588 |
| 17 | TYK2 | 2.11174619 |
| 18 | CSK | 2.02552787 |
| 19 | NTRK2 | 1.95788333 |
| 20 | NTRK1 | 1.93864380 |
| 21 | SIK2 | 1.88826726 |
| 22 | RIPK1 | 1.81112013 |
| 23 | BTK | 1.77941334 |
| 24 | MAP2K7 | 1.72895610 |
| 25 | MAP3K11 | 1.70318130 |
| 26 | MAP3K14 | 1.69735143 |
| 27 | MAP2K4 | 1.68682739 |
| 28 | SYK | 1.65483435 |
| 29 | TAOK1 | 1.64041260 |
| 30 | MAP3K3 | 1.59559235 |
| 31 | TRIB3 | 1.58617937 |
| 32 | STK38 | 1.58168426 |
| 33 | ERN1 | 1.57707607 |
| 34 | JAK3 | 1.55542853 |
| 35 | CDK5 | 1.54765481 |
| 36 | GRK6 | 1.53485029 |
| 37 | FES | 1.52857476 |
| 38 | DAPK1 | 1.49223073 |
| 39 | LMTK2 | 1.48485224 |
| 40 | MAP3K2 | 1.46308752 |
| 41 | CAMK1G | 1.42975634 |
| 42 | IRAK4 | 1.41745699 |
| 43 | CSF1R | 1.40201082 |
| 44 | CAMKK2 | 1.40140495 |
| 45 | TEC | 1.37630496 |
| 46 | RET | 1.34885492 |
| 47 | KIT | 1.32577337 |
| 48 | MATK | 1.31364615 |
| 49 | SGK3 | 1.31165319 |
| 50 | PRKCH | 1.28342125 |
| 51 | ALK | 1.26128798 |
| 52 | TXK | 1.25445827 |
| 53 | SCYL2 | 1.22029605 |
| 54 | MAP3K13 | 1.20971354 |
| 55 | TGFBR2 | 1.20498410 |
| 56 | TBK1 | 1.17672906 |
| 57 | GRK5 | 1.15820309 |
| 58 | EPHB1 | 1.10475233 |
| 59 | PHKG2 | 1.09723729 |
| 60 | PHKG1 | 1.09723729 |
| 61 | TAOK3 | 1.09482918 |
| 62 | MAP3K12 | 1.07964686 |
| 63 | ITK | 1.06798507 |
| 64 | LYN | 1.06285506 |
| 65 | SGK2 | 1.05973732 |
| 66 | KSR1 | 1.05284723 |
| 67 | LCK | 1.03880756 |
| 68 | CAMK1D | 1.02827607 |
| 69 | MAP3K6 | 1.02537658 |
| 70 | STK11 | 1.00982651 |
| 71 | SGK494 | 0.99983522 |
| 72 | SGK223 | 0.99983522 |
| 73 | TYRO3 | 0.99937309 |
| 74 | PDK1 | 0.97838178 |
| 75 | PDPK1 | 0.94626421 |
| 76 | CAMK1 | 0.93110715 |
| 77 | IKBKE | 0.91901054 |
| 78 | PRKD2 | 0.90099057 |
| 79 | DYRK3 | 0.89777118 |
| 80 | MAPK13 | 0.89038503 |
| 81 | TNIK | 0.86566698 |
| 82 | STK10 | 0.85126386 |
| 83 | PRPF4B | 0.84891164 |
| 84 | PKN2 | 0.84063807 |
| 85 | IKBKB | 0.81452166 |
| 86 | BMPR2 | 0.81236077 |
| 87 | TNK2 | 0.79215425 |
| 88 | SGK1 | 0.78131440 |
| 89 | MARK2 | 0.77010682 |
| 90 | PRKCG | 0.76772676 |
| 91 | HIPK2 | 0.75236170 |
| 92 | TESK2 | 0.74620593 |
| 93 | MAP3K1 | 0.71239245 |
| 94 | PTK2B | 0.70347191 |
| 95 | YES1 | 0.70331606 |
| 96 | LATS2 | 0.70293512 |
| 97 | CDK15 | 0.69685849 |
| 98 | KDR | 0.69521829 |
| 99 | IRAK1 | 0.69033259 |
| 100 | MAP3K7 | 0.68688357 |
| 101 | CDC42BPA | 0.68200240 |
| 102 | RPS6KA2 | 0.67962439 |
| 103 | UHMK1 | 0.67393685 |
| 104 | FYN | 0.66478358 |
| 105 | CDK18 | 0.66003682 |
| 106 | CDK19 | 0.64899493 |
| 107 | PLK2 | 0.64802208 |
| 108 | WNK1 | 0.64304256 |
| 109 | IRAK3 | 0.63467533 |
| 110 | DMPK | 0.61645011 |
| 111 | FGFR3 | 0.61353727 |
| 112 | MARK3 | 0.60542996 |
| 113 | CAMK4 | 0.59991653 |
| 114 | CDK14 | 0.59988993 |
| 115 | CDK11A | 0.57917785 |
| 116 | JAK2 | 0.57406519 |
| 117 | PRKD1 | 0.56413495 |
| 118 | JAK1 | 0.55995146 |
| 119 | BMX | 0.55301203 |
| 120 | RPS6KC1 | 0.55102142 |
| 121 | RPS6KL1 | 0.55102142 |
| 122 | RPS6KA3 | 0.54113892 |
| 123 | PRKG2 | 0.53989691 |
| 124 | FGFR4 | 0.52608998 |
| 125 | RAF1 | 0.52599981 |
| 126 | TRPM7 | 0.52355436 |
| 127 | PIK3CG | 0.52344588 |
| 128 | EEF2K | 0.51913336 |
| 129 | PRKCZ | 0.50391234 |
| 130 | BRSK1 | 0.50029697 |
| 131 | MAPK7 | 0.50017442 |
| 132 | RPS6KA6 | 0.49621539 |
| 133 | PDGFRA | 0.49517091 |
| 134 | IRAK2 | 0.48220704 |
| 135 | PRKCQ | 0.47977653 |
| 136 | PINK1 | 0.47813458 |
| 137 | MAPK12 | 0.47258691 |
| 138 | MAPKAPK3 | 0.46330045 |
| 139 | TIE1 | 0.46141591 |
| 140 | MAPK10 | 0.44262085 |
| 141 | FER | 0.43577261 |
| 142 | MAP2K6 | 0.41377908 |
| 143 | EPHA3 | 0.40796218 |
| 144 | DAPK3 | 0.40098183 |
| 145 | CAMK2A | 0.39634844 |
| 146 | PTK6 | 0.39596156 |
| 147 | HCK | 0.39352020 |
| 148 | MAP2K1 | 0.39215894 |
| 149 | NEK1 | 0.39049962 |
| 150 | DYRK1A | 0.39026097 |
| 151 | FGR | 0.38984636 |
| 152 | LRRK2 | 0.37180736 |
| 153 | ARAF | 0.36284278 |
| 154 | ICK | 0.34840043 |
| 155 | MAPK8 | 0.33240576 |
| 156 | ERBB2 | 0.33033754 |
| 157 | PDGFRB | 0.31820710 |
| 158 | * SRC | 0.31289298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.73204231 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.54098265 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.52731762 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.41720523 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.37590050 |
| 6 | * Olfactory transduction_Homo sapiens_hsa04740 | 2.24627380 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.22634852 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19352895 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.17086346 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.15384296 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.11854617 |
| 12 | * Morphine addiction_Homo sapiens_hsa05032 | 2.02266272 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.00238184 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.99481241 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.90412317 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87183487 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.86028228 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.74032482 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71203674 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.70187525 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.70149570 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.68365675 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.68001903 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.65330890 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61639272 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.58621558 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55662395 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.55110686 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.53270804 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.50254749 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47355769 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46173495 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43265544 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.43002517 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41290326 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.39243924 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39207651 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.37314706 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.34697323 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33831392 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.31454638 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.29694933 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.29001792 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27620971 |
| 45 | Gap junction_Homo sapiens_hsa04540 | 1.27619560 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27087006 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.26828126 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26088738 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25923242 |
| 50 | Asthma_Homo sapiens_hsa05310 | 1.22839915 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21995024 |
| 52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21334140 |
| 53 | Taste transduction_Homo sapiens_hsa04742 | 1.20990049 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19492624 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19476091 |
| 56 | Pertussis_Homo sapiens_hsa05133 | 1.18920237 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.18172864 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18046619 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16157664 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15269107 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13591100 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12909942 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 1.11343538 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10316317 |
| 65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07640335 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.07078025 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04474319 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03020065 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03003196 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 1.01865154 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01428593 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01338552 |
| 73 | Measles_Homo sapiens_hsa05162 | 1.00531844 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98196745 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98126862 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97813076 |
| 77 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96646225 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95034944 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93760415 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93705227 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92852549 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90466595 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90300958 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86881458 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.85244243 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84921327 |
| 87 | Axon guidance_Homo sapiens_hsa04360 | 0.84503992 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83863687 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83079573 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.82285313 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81242516 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80745174 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79731096 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79401461 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79273021 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78921500 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.77596061 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76220852 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74682767 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74566513 |
| 101 | * Endocytosis_Homo sapiens_hsa04144 | 0.74250085 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72813727 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.72097182 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71975808 |
| 105 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71934843 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.71518065 |
| 107 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71445461 |
| 108 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70384098 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.70079604 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.69935934 |
| 111 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69861187 |
| 112 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69017073 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68929448 |
| 114 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67891161 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.67774988 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67629764 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66804432 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64227632 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62045211 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61934230 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61381555 |
| 122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60994640 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.59321364 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.59193912 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57704014 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57142611 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56475400 |
| 128 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55028637 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54605842 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.53381459 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51894481 |
| 132 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50980235 |
| 133 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50523309 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49648290 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49361910 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48799638 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48077993 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47871703 |
| 139 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46559819 |
| 140 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46310342 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45877158 |
| 142 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45560654 |
| 143 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44909214 |
| 144 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44446008 |
| 145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43798854 |
| 146 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43213738 |
| 147 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42357231 |
| 148 | Tuberculosis_Homo sapiens_hsa05152 | 0.41948271 |
| 149 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39168929 |

